172 related articles for article (PubMed ID: 35665853)
61. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty.
Nagar M; Luhishi E; Shah N
Br J Ophthalmol; 2009 Apr; 93(4):497-501. PubMed ID: 19106150
[TBL] [Abstract][Full Text] [Related]
62. Effect of Apraclonidine and Diclofenac on Early Changes in Intraocular Pressure After Selective Laser Trabeculoplasty.
Thrane VR; Thrane AS; Bergo C; Halvorsen H; Krohn J
J Glaucoma; 2020 Apr; 29(4):280-286. PubMed ID: 32053556
[TBL] [Abstract][Full Text] [Related]
63. Selective laser trabeculoplasty lowered the untreated fellow eye long-term intraocular pressure: a 3-year observational study.
Liu Y; Fan X; Wu L
Lasers Med Sci; 2022 Apr; 37(3):1487-1493. PubMed ID: 34350528
[TBL] [Abstract][Full Text] [Related]
64. Predictors of Success in Selective Laser Trabeculoplasty: Data From the Lausanne Laser Trabeculoplasty Registry.
Elahi S; Rao HL; Dumitru A; Mansouri K
J Glaucoma; 2020 Jul; 29(7):550-555. PubMed ID: 32398589
[TBL] [Abstract][Full Text] [Related]
65. TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA.
Vié AL; Kodjikian L; Malclès A; Agard E; Voirin N; El Chehab H; Nguyen AM; Dot C
Retina; 2017 Jan; 37(1):173-178. PubMed ID: 27465569
[TBL] [Abstract][Full Text] [Related]
66. Efficacy and Safety of High-Energy Selective Laser Trabeculoplasty for Steroid-Induced Glaucoma in Patients with Quiescent Uveitis.
Xiao J; Zhao C; Liang A; Zhang M; Cheng G
Ocul Immunol Inflamm; 2021 May; 29(4):766-770. PubMed ID: 31902258
[No Abstract] [Full Text] [Related]
67. Efficacy and safety of selective laser trabeculoplasty as a primary procedure for controlling intraocular pressure in primary open angle glaucoma and ocular hypertensive patients.
Mahdy MA
Sultan Qaboos Univ Med J; 2008 Mar; 8(1):53-8. PubMed ID: 21654957
[TBL] [Abstract][Full Text] [Related]
68. [Two-year outcomes of selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension].
Zaninetti M; Ravinet E
J Fr Ophtalmol; 2008 Dec; 31(10):981-6. PubMed ID: 19107074
[TBL] [Abstract][Full Text] [Related]
69. Optimal Performance of Selective Laser Trabeculoplasty: Results from the Swedish Optimal SLT Multicenter Randomized Controlled Trial.
Dahlgren T; Ayala M; Zetterberg M
Ophthalmol Glaucoma; 2024; 7(2):105-115. PubMed ID: 37838088
[TBL] [Abstract][Full Text] [Related]
70. 10-year outcomes of first-line selective laser trabeculoplasty (SLT) for primary open-angle glaucoma (POAG).
Ansari E
Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1597-1604. PubMed ID: 33576857
[TBL] [Abstract][Full Text] [Related]
71. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with open-angle glaucoma: a systematic review and meta-analysis.
Wang W; He M; Zhou M; Zhang X
PLoS One; 2013; 8(12):e84270. PubMed ID: 24367649
[TBL] [Abstract][Full Text] [Related]
72. Comparing pattern scanning laser trabeculoplasty to selective laser trabeculoplasty: A randomized controlled trial.
Mansouri K; Shaarawy T
Acta Ophthalmol; 2017 Aug; 95(5):e361-e365. PubMed ID: 27778483
[TBL] [Abstract][Full Text] [Related]
73. Is laser trabeculoplasty the new star in glaucoma treatment?
Töteberg-Harms M; Meier-Gibbons F
Curr Opin Ophthalmol; 2021 Mar; 32(2):141-147. PubMed ID: 33470670
[TBL] [Abstract][Full Text] [Related]
74. [Effects of selective laser trabeculoplasty treatment in steroid-induced glaucoma].
Tokuda N; Inoue J; Yamazaki I; Matsuzawa A; Munemasa Y; Kitaoka Y; Takagi H; Ueno S
Nippon Ganka Gakkai Zasshi; 2012 Aug; 116(8):751-7. PubMed ID: 22973739
[TBL] [Abstract][Full Text] [Related]
75. [Selective laser trabeculoplasty treatment for medication-refractory open angle glaucoma].
Geyer O; Wolf A; Levinger E; Orev T; Segev E
Harefuah; 2005 Nov; 144(11):790-3, 822, 821. PubMed ID: 16358655
[TBL] [Abstract][Full Text] [Related]
76. [Meta-analysis of randomized controlled trials comparing selective laser trabeculoplasty with prostaglandin analogue in the primary treatment of open-angle glaucoma or ocular hypertention].
Peng W; Zhong X; Yu M
Zhonghua Yan Ke Za Zhi; 2014 May; 50(5):343-8. PubMed ID: 25052803
[TBL] [Abstract][Full Text] [Related]
77. [The efficacy of low-energy selective laser trabeculoplasty].
Tang M; Fu Y; Ma Y; Fu MS; Fan Y; Sun XD; Xu X
Zhonghua Yan Ke Za Zhi; 2011 Oct; 47(10):887-92. PubMed ID: 22321497
[TBL] [Abstract][Full Text] [Related]
78. Baseline intraocular pressure: an independent risk factor in severe steroid-induced ocular hypertension after intravitreal dexamethasone implant.
Cho WJ; Lee JM; Bae HW; Kim CY; Seong GJ; Choi W
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1231-1243. PubMed ID: 37930443
[TBL] [Abstract][Full Text] [Related]
79. OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
Chin EK; Almeida DRP; Velez G; Xu K; Peraire M; Corbella M; Elshatory YM; Kwon YH; Gehrs KM; Boldt HC; Sohn EH; Russell SR; Folk JC; Mahajan VB
Retina; 2017 Jul; 37(7):1345-1351. PubMed ID: 27806001
[TBL] [Abstract][Full Text] [Related]
80. Argon versus selective laser trabeculoplasty.
Van de Veire S; Zeyen T; Stalmans I
Bull Soc Belge Ophtalmol; 2006; (299):5-10. PubMed ID: 16681083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
